title: Left ventricular assist device bridge therapy for acute myocardial infarction.
abstract: BACKGROUND
  Patients with acute myocardial infarction (AMI) complicated by cardiogenic shock have a high mortality rate. Current treatment modalities remain suboptimal for these patients.
  
  
  METHODS
  From April 1995 to March 1998, 7 patients were identified as having AMI associated with cardiogenic shock. All received intraaortic balloon pump assistance, in addition to maximal inotropic support.
  
  
  RESULTS
  The mean preoperative cardiac index was 2.0+/-0.3 L/min/m2 and pulmonary capillary wedge pressure was 23+/-6 mm Hg. Three patients received thrombolytic therapy and 4 patients underwent percutaneous transluminal coronary angioplasty without success. Left ventricular assist devices (LVADs) were implanted as bridge therapy to heart transplantation. One patient died from recurrence of a ventricular septal defect during LVAD support. Six patients were transplanted successfully after mean LVAD support of 59+/-33 days. Five patients are alive and well at a mean follow-up of 898+/-447 days. One patient died 3 days after transplantation from acute allograft dysfunction.
  
  
  CONCLUSIONS
  Timely application of LVADs as bridge therapy to heart transplantation in these critically ill patients can be lifesaving, and should be investigated further.
authors.affiliation: Division of Cardiovascular and Thoracic Surgery, University of Minnesota Hospital and Clinic, Minneapolis, USA. parkx021@maroon.tc.umn.edu
authors.forename: S J
authors.initials: SJ
authors.lastname: Park
authors.forename: D Q
authors.initials: DQ
authors.lastname: Nguyen
authors.forename: A J
authors.initials: AJ
authors.lastname: Bank
authors.forename: S
authors.initials: S
authors.lastname: Ormaza
authors.forename: R M
authors.initials: RM
authors.lastname: Bolman
mesh_terms: D000328:Adult; D015906:Angioplasty, Balloon, Coronary; D005260:Female; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012770:Shock, Cardiogenic / Q000628:therapy*; D015912:Thrombolytic Therapy; D016896:Treatment Outcome